Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms, Genomenon Team on Analytics for Rare Disease Dx, Research

NEW YORK – BC Platforms and Genomenon said Tuesday that they have agreed to combine their technologies for rare disease diagnostics and research.

The collaboration calls on Genomenon to integrate its Mastermind genomic search engine into two BC Platforms products: the BC|Genome genomic interpretation and analysis platform to support molecular diagnostics and other forms of clinical genomics; and discovery and insight system BC|Insight on the research side. Mastermind accelerates variant interpretation with the help of machine learning.

"Genomenon is a natural partner for us, as both companies are passionate about powering evidence-based genomics," BC Platforms CEO Tero Silvola said in a statement. "This is about super-charging data-driven decision-making in healthcare."

Further terms of the alliance were not disclosed.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.